SCHEMBL6897434

SCHEMBL6897434

CCc1cc(O)c2c3c(C(=O)OC)cccc3n(Cc3cccc(Cc4ccccc4)c3)c2c1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.39
ALDH1A1 P00352 2/20 0.39
GAA P10253 1/20 0.39
PKM P14618 1/20 0.39
PLA2G2A P14555 5/20 0.38
MPO P05164 1/20 0.37
TSHR P16473 2/20 0.37
THRB P10828 1/20 0.37
F10 P00742 2/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
KDM4E B2RXH2 1/20 0.36
USP2 O75604 1/20 0.36
HPGD P15428 1/20 0.36
HSD17B10 Q99714 1/20 0.36
MTNR1A P48039 1/20 0.36
MTNR1B P49286 1/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6894814 0.93 MAPT (0.44) MAPTALDH1A1GAAPKMPLA2G2A
SCHEMBL6888047 0.91 CNR1 (0.38) MAPTALDH1A1GAAPKMMEN1
SCHEMBL6892160 0.91 PLA2G2A (0.44) MAPTALDH1A1GAAPKMPLA2G2A
SCHEMBL6898378 0.90 ACMSD (0.39) MAPTALDH1A1GAAPKMPLA2G2A
SCHEMBL6897303 0.90 PLA2G2A (0.42) MAPTALDH1A1GAAPKMPLA2G2A
SCHEMBL6897168 0.90 PLA2G1B (0.44) MAPTALDH1A1GAAPKMPLA2G2A
SCHEMBL6894729 0.90 MAPT (0.41) MAPTALDH1A1GAAPKMPLA2G2A
SCHEMBL6896777 0.89 FAAH (0.44) MAPTALDH1A1GAAPKMTHRB
SCHEMBL6777282 0.89 PLA2G2A (0.41) PLA2G2A
SCHEMBL6889689 0.88 MAPT (0.47) MAPTALDH1A1GAAPKMTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6713645-B1 INHIBITING SPLA2 MEDIATED RELEASE OF FATTY ACIDS FOR TREATMENT OF CONDITIONS SUCH AS SEPTIC SHOCK ELI LILLY AND COMPANY 2004-03-30 US disclosed
US-6177440-B1 THERAPY FOR SEPSIS SHOCK; PHOSPHOLIPASE INHBITOR ELI LILLY AND COMPANY 2001-01-23 US disclosed
EP-0952149-A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors ELI LILLY AND COMPANY (US) 1999-10-27 EP disclosed